跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,408 条关于
“BCMA-targeted bispecific antibody”
全部
28,408
临床试验
12,626
药物
3,403
机构
103
资讯
12,276
去年
Regeneron Secures FDA Approval for BCMA-Targeted Bispecific Antibody in Multiple Myeloma
去年
BCMA-Targeted Bispecific Antibody CM336 Shows Promise for Refractory Autoimmune Hemolytic Anemia in NEJM Study
2年前
Novel Targets and Strategic Sequencing: The Evolving Landscape of T-Cell Redirection Therapies in Multiple Myeloma
3年前
14 Breakthrough Drugs Poised for Blockbuster Status by 2027: Clarivate Analysis
去年
Teclistamab Shows Sustained Efficacy in Relapsed/Refractory Multiple Myeloma
2年前
Real-World Teclistamab Data Shows Comparable Efficacy to Clinical Trials Despite Higher Toxicity Rates in Multiple Myeloma
去年
Cullinan Therapeutics Licenses BCMA-Targeted Bispecific T Cell Engager for Autoimmune Disease Development
去年
Novel Therapies Show Promise in Melanoma, Breast, and Prostate Cancers
8年前
GSK's BCMA-Targeting ADC, GSK2857916, Receives FDA Breakthrough Therapy Designation for Multiple Myeloma
去年
China Approves Zanidatamab as First Dual HER2-Targeted Bispecific Antibody for Biliary Tract Cancer
第 1 页，共 1228 页
上一页
下一页
